Last year, the government of Burkina Faso terminated the Target Malaria project, a research initiative funded by the Gates Foundation and Open Philanthropy, due to biosafety risks, low impact and scientific sovereignty concerns.
Target Malaria aims to use genetically modified mosquitoes to control malaria. It is not the only mosquito project Gates has invested in. Gates has also invested in Oxitech’s genetically modified mosquito programmes. But his ambitions don’t stop there.
The Gates Foundation has also funded projects releasing mosquitoes infected with a modified Wolbachia bacteria. This method of assaulting the natural world is born out of the Australian ‘World Mosquito Programme’.
In Colombia, the World Mosquito Programme has been releasing 30 million Wolbachia-infected mosquitoes a week.
What is Wolbachia?
Aucun commentaire:
Enregistrer un commentaire